Evaluation and Management of Virologic Failure
10 questions
Learning Objectives
- Describe the management of intermittent and persistently detectable HIV RNA levels in persons receiving antiretroviral therapy
- Discuss the indications for and types of resistance testing for patients with virologic failure
- Utilize an HIV resistance database tool to assist in the optimal selection of regimens in persons with HIV drug resistance
- Summarize concepts of resistance with different antiretroviral drug classes
- Explain key considerations when selecting a salvage antiretroviral regimen in persons with virologic failure
Authors
Reviewers
3rd Edition
This is a substantial revision of the original Question Bank Topic. The previous edition was titled Evaluation and Management of Virologic Failure and available until September 1st, 2023.
CNE/CME Continuing Education
This question bank topic qualifies for:
View CE Notices
- 1 CME AMA PRA Category 1 Credit™, or
- 1 CNE contact hour (qualifies for pharmacology CE for advanced practice nurses)
CNE and CME Origination: June 1st, 2017
CNE and CME Reviewed: September 1st, 2023
CNE and CME Expiration: August 31st, 2026 (3rd Edition)
View CE Notices
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5
Print Certificate
Obtain proof of CE Explore this topic in detail in the Evaluation and Management of Virologic Failure Quick Reference,
or earn more CE for it in the Evaluation and Management of Virologic Failure Self-Study
or earn more CE for it in the Evaluation and Management of Virologic Failure Self-Study